Key Findings
The North American market for active pharmaceutical ingredients shelters the presence of highly established and regulated pharmaceutical industry, a factor that has been primarily responsible for the region for capturing the largest market share in 2018 in the global API market. As per the market analysis by Inkwood Research, the regional market is expected to escalate at a CAGR of 5.05% during the forecasting years of 2019-2027.

Market Insights
The intensive technological development coupled with high economic growth in the North American region is chiefly driving the market growth. Additionally, the increasing prevalence of cancer and other lifestyle-induced diseases is responsible for tremendous growth in R&D activities for drugs. Furthermore, the majority of the pharmaceutical players are based on this region.

The United States and Canada are considered for the market study of the region. The US market is expected to hold the largest market share by the end of 2027, mainly because of the rising prevalence of lifestyle-inducing diseases such as diabetes and cardiovascular disorders, which is further increasing the demand for more effective drugs.

Competitive Insights
Boehringer Ingelheim GmbH, Novartis, Eli Lilly and Company, Albemarle Corporation, Aurobindo Pharma, Lonza Group AG, Dr. Reddy’s Laboratories, Cipla, Merck & Co., Inc., Bayer AG, AbbVie, Inc., Bristol-Myers Squibb, Mylan N.V., Teva Pharmaceutical Industries, Ltd., and Sun Pharmaceuticals Industries, Ltd. are the major companies that are operating in the region that have been comprehensively profiled in the report.